Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001683168-24-001108
Filing Date
2024-02-22
Accepted
2024-02-22 07:55:22
Documents
16
Period of Report
2024-02-15
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K AMENDMENT canna_8k.htm   iXBRL 8-K/A 29599
2 SUPPLY AGREEMENT canna_ex0101.htm EX-1.1 185977
3 PRESS RELEASE canna_ex9901.htm EX-99.1 7743
  Complete submission text file 0001683168-24-001108.txt   439742

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cpmd-20240215.xsd EX-101.SCH 3030
5 XBRL LABEL FILE cpmd-20240215_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE cpmd-20240215_pre.xml EX-101.PRE 22369
17 EXTRACTED XBRL INSTANCE DOCUMENT canna_8k_htm.xml XML 3844
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

EIN.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-27055 | Film No.: 24662351
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)